119 related articles for article (PubMed ID: 10601976)
1. Effects of complexation with in vivo enhancing monoclonal antibodies on activity of growth hormone in two responsive cell culture systems.
Beattie J; Borromeo V; Bramani S; Secchi C; Baumbach WR; Mockridge J
J Mol Endocrinol; 1999 Dec; 23(3):307-13. PubMed ID: 10601976
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition of recombinant bovine GH (rbGH) activity in vitro by in vivo enhancing monoclonal antibodies.
Beattie J; Phillips K; Borromeo V
Mol Cell Biochem; 2001 Apr; 220(1-2):103-8. PubMed ID: 11451369
[TBL] [Abstract][Full Text] [Related]
3. Binding and signalling properties of a growth hormone enhancing monoclonal antibody.
Beattie J; Bramani S; Secchi C; Mockridge J
Mol Cell Biochem; 1999 Aug; 198(1-2):61-7. PubMed ID: 10497879
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of hybrid ovine/rat GH receptors to oGH and rat GH in transfected FDC-P1 mouse myeloid cells in vitro.
Beattie J; Phillips K; Shand JH; Brocklehurst S; Flint DJ; Allan GJ
Mol Cell Biochem; 2002 Sep; 238(1-2):137-43. PubMed ID: 12349901
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of the growth hormone (GH) receptor and Janus tyrosine kinase-2 is involved in the insulin-like actions of GH in primary rat adipocytes.
Eriksson H; Ridderstråle M; Tornqvist H
Endocrinology; 1995 Nov; 136(11):5093-101. PubMed ID: 7588246
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of bovine growth hormone activity in vivo by monoclonal antibodies.
Aston R; Holder AT; Ivanyi J; Bomford R
Mol Immunol; 1987 Feb; 24(2):143-50. PubMed ID: 2441248
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to bovine growth hormone potentiate hormonal activity in vivo by enhancing growth hormone binding to hepatic somatogenic receptors.
Massart S; Maiter D; Portetelle D; Adam E; Renaville R; Ketelslegers JM
J Endocrinol; 1993 Dec; 139(3):383-93. PubMed ID: 8133207
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-induced antagonism of growth hormone (GH) action by down-regulation of GH binding in 3T3-F442A fibroblasts.
King AP; Carter-Su C
Endocrinology; 1995 Nov; 136(11):4796-803. PubMed ID: 7588209
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
11. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
[TBL] [Abstract][Full Text] [Related]
12. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
13. A role for Grb2-associated binder-1 in growth hormone signaling.
Kim SO; Loesch K; Wang X; Jiang J; Mei L; Cunnick JM; Wu J; Frank SJ
Endocrinology; 2002 Dec; 143(12):4856-67. PubMed ID: 12446613
[TBL] [Abstract][Full Text] [Related]
14. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
15. Evidence for association of the cloned liver growth hormone receptor with a tyrosine kinase.
Wang X; Uhler MD; Billestrup N; Norstedt G; Talamantes F; Nielsen JH; Carter-Su C
J Biol Chem; 1992 Aug; 267(24):17390-6. PubMed ID: 1380961
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the somatogenic activity of bovine placental lactogen with cell lines transfected with the bovine somatotropin receptor.
Warren WC; Byatt JC; Huynh M; Paik K; Pegg G; Staten NR
Life Sci; 1999; 65(25):2755-67. PubMed ID: 10622285
[TBL] [Abstract][Full Text] [Related]
17. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes.
Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X
Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH)-induced tyrosine-phosphorylated proteins in cells that express GH receptors.
Harding PA; Wang XZ; Kopchick JJ
Receptor; 1995; 5(2):81-92. PubMed ID: 7580939
[TBL] [Abstract][Full Text] [Related]
19. Stimulation by growth hormone (GH) of GH receptor-associated tyrosine kinase activity.
Stred SE; Stubbart JR; Argetsinger LS; Smith WC; Shafer JA; Talamantes F; Carter-Su C
Endocrinology; 1992 Mar; 130(3):1626-36. PubMed ID: 1537311
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
